ArticleFrontiers in immunology2026

Homoeriodictyol, targeting the bitter taste receptor TAS2R14, lowers the secretion of pro-inflammatory chemokines upon treatment with SARS-CoV-2 peptide pools in human peripheral blood mononuclear cells.

Barbara Danzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.